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serum chloride are associated with acute
kidney injury in severe sepsis and septic
shock patients
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Abstract
Background: Acute kidney injury and hyperchloremia are commonly present in critically ill septic patients. Our
study goal was to evaluate the association of hyperchloremia and acute kidney injury in severe sepsis and septic
shock patients.
Methods: In this retrospective cohort study in a provincial tertiary care hospital, adult patients with severe sepsis or
septic shock and serum chloride measurements were included. Serum chloride was measured on a daily basis for
48 hours. Primary outcome was development of acute kidney injury (AKI) and association of AKI and serum chloride
parameters was analyzed.
Results: A total of 240 patients were included in the study, 98 patients (40.8 %) had hyperchloremia. The incidence
of acute kidney injury (AKI) was significantly higher in the hyperchloremia group (85.7 % vs 47.9 %; p < 0.001).
Maximal chloride concentration in the first 48 hours ([Cl-]max) was significantly associated with AKI. In multivariate
analysis, [Cl-]max was independently associated with AKI [adjusted odds ratio (OR) for AKI = 1.28 (1.02–1.62); p = 0.037]. The
increase in serum chloride (Δ[Cl-] = [Cl-]max – initial chloride concentration) demonstrated a dose-dependent relationship
with severity of AKI. The mean Δ[Cl-] in patients without AKI was 2.1 mmol/L while in the patients with AKI stage 1, 2
and 3 the mean Δ[Cl-] was 5.1, 5.9 and 6.7 mmol/L, respectively. A moderate increase in serum chloride (Δ[Cl-]≥
5 mmol/L) was associated with AKI [OR = 5.70 (3.00–10.82); p < 0.001], even in patients without hyperchloremia
[OR = 8.25 (3.44–19.78); p < 0.001].
Conclusions: Hyperchloremia is common in severe sepsis and septic shock and independently associated with AKI. A
moderate increase in serum chloride (Δ[Cl-] ≥5 mmol/L) is associated with AKI even in patients without hyperchloremia.
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Background
Acute kidney injury (AKI) frequently occurs in patients
with severe sepsis and septic shock [1]. A small rise in
serum creatinine (26.5 μmol/L) in critically ill patients is
associated with higher mortality, longer length of stay,
greater need of vasopressor and mechanical ventilator
support and worse long-term outcomes [2–5]. Identify-
ing risk factors for development of AKI in sepsis may
therefore be helpful to understand and avoid this
profound complication.
Intravenous fluid resuscitation to restore effective cir-
culatory volume in severely ill septic patients is a main-
stay of early therapy of severe sepsis and septic shock.
The Surviving Sepsis Campaign International Guidelines
recommends crystalloids as the initial fluid of choice for
resuscitation of septic shock patients [6]. Normal 0.9 %
saline solution (Saline), is the most common isotonic
crystalloid solution used for resuscitation globally [7–9].
However, the electrolyte composition of Saline is quite
different from serum electrolyte composition; Saline has
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50 % greater chloride than serum (154 vs 100 mmol/L,
respectively) [10]. Consequently, hyperchloremic meta-
bolic acidosis is a common consequence of chloride-rich
solution resuscitation [11, 12].
Animal and human studies demonstrate that infusion
of Saline results in decreased renal blood flow, reduced
glomerular filtration rate, and delayed time to mictur-
ition [13–15]. In an animal model of sepsis, resuscitation
with Saline resulted in a higher incidence of AKI com-
pared to a balanced crystalloid solution with a more
physiologic chloride concentration [16]. A recent study
conducted by Yunos and colleagues [17] in critically ill
adults found that restriction of chloride-rich fluid was
associated with a significant decrease in the incidence of
AKI and need for renal replacement therapy (RRT).
However, a subsequent randomized controlled trial of
normal saline vs. a balanced solution (Plasma-Lyte)
found no difference in development of AKI. However,
patients were unselected ICU patients, the exposure was
only 2 L over the ICU stay, no renal biomarkers were
measured, and the serum chloride was not reported.
Thus it remains controversial how to manage fluids and
chloride in the critically ill. To date, the association of
hyperchloremia and AKI has been observed in unse-
lected critically ill patients [18] but not specifically in
septic patients [19, 20].
Rapid volume resuscitation of septic patients with
Saline rapidly changes serum chloride concentration.
Despite all of the above work, it is unclear whether AKI
associated with chloride-rich volume resuscitation is due
to the absolute value of serum chloride rising above a
threshold – hyperchloremia – or whether the change of
serum chloride concentration is more important. For ex-
ample, a rapid increase in serum sodium concentration
(rather than the absolute serum sodium concentration)
can lead to central pontine myelinolysis.
Accordingly we first tested the hypothesis that hyper-
chloremia after volume resuscitation was associated with
AKI in severe sepsis and septic shock patients. Second,
we determined whether the change of serum chloride
concentration resulting from volume resuscitation was
associated with AKI in severe sepsis and septic shock
patients.
Methods
Study design and participants
This study was a retrospective cohort study of patients
with severe sepsis or septic shock admitted to St. Paul’s
Hospital in Vancouver, a tertiary care referral hospital,
from January 2011 to April 2015. We included all adults
patients with the following criteria: (1) 18 years or older;
(2) diagnosis of severe sepsis (defined by two of four Sys-
temic Inflammatory Response Syndrome (SIRS) criteria
plus a suspected or confirmed source of infection with
at least one organ dysfunction or a lactate greater than
4 mmol/L) or septic shock (defined by sepsis-induced
hypotension, tissue hypoperfusion or vasopressor re-
quirement); and (3) initial serum chloride and daily
serum chloride concentration for the first 48 hours were
measured. We excluded patients with pre-existing
chronic renal failure or chronic use of RRT. Written in-
formed consent was obtained from all patients or their
representative and the study protocol was approved by
our institutional ethics board.
All of these patients were diagnosed via an institutional
sepsis protocol in the Emergency Department. Study
screening was triggered by this protocol. Most of the re-
suscitation was conducted by Emergency Department
physicians. The primary resuscitation fluid was Saline.
Thirty-seven percent of these patients were admitted to
the ICU and managed by the attending intensivist.
The treatment of these patients was evaluated and di-
rected by attending physicians without a resuscitation
guideline or protocol.
Study variables
Serum chloride concentration was measured by indirect
potentiometry (ADVIA 1800 Chemistry System; Siemens
Healthcare Diagnostic Inc., Oakville, ON, Canada). The
initial chloride concentration, [Cl-]0 was the initial serum
chloride concentration measured at the time that the pa-
tient fulfilled diagnostic criteria for severe sepsis or sep-
tic shock (above). Serum chloride concentration was
measured at least daily for the first 48 hours and the
maximal serum chloride concentration during this time
period was designated as [Cl-]max. The increase in serum
chloride, Δ[Cl-], was the difference between maximal
serum chloride level and initial serum chloride level
(Δ[Cl-] = [Cl-]max - [Cl
-]0). Hyperchloremia was defined
as [Cl-]max ≥ 110 mmol/L [20].
The Acute Physiology and Chronic Health Evaluation II
(APACHE II) score was determined by using clinical and
laboratory data on the first day of enrollment. AKI was
diagnosed and classified by Kidney Disease Improving
Global Outcomes (KDIGO) consensus criteria by an
increase in serum creatinine concentration > 50 %
from a baseline creatinine concentration measured within
3 months prior to enrollment [21]. If a previous serum
creatinine was not available, it was calculated by assuming
that the glomerular filtration rate (GFR) of the patient was
75 mL/min per 1.73 m2 and serum creatinine concentra-
tion was computed using the modified 4-variable Modifi-
cation of Diet in Renal Disease (MDRD) formula [22].
Study outcomes
The primary outcome was development of AKI by
KDIGO criteria. The secondary outcomes were require-
ment of RRT and 28-day mortality.
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Statistical analysis
Demographic and clinical data were compared between pa-
tients with hyperchloremia and without hyperchloremia.
Continuous data were reported by using mean ± standard
deviation (SD) or median (interquartile range) and categor-
ical data as percentage. We used t tests to compare
normally distributed continuous data and Wilcoxon
signed-rank tests for non-normally distributed data. For
categorical variables, a chi-square test was used.
Logistic regression was used to test for association of
chloride parameters ([Cl-]0, [Cl
-]max and Δ[Cl
-], hyper-
chloremia) with AKI, RRT, and 28-day mortality. Univar-
iate logistic regression was used to test for unadjusted
association between chloride parameters and AKI.
Multivariate logistic regression was used to test for asso-
ciations between chloride parameters and AKI after
adjusting for potentially confounding covariates. Inde-
pendent variables with p < 0.1 in univariate models were
incorporated as covariates into the multivariate regres-
sion model. These variables consisted of demographic
data (age, gender), underlying diseases (hypertension,
congestive heart failure, chronic obstructive pulmonary
disease) and clinical severity at presentation (APACHE II
score, serum lactate, requirement of vasopressor, mech-
anical ventilator requirement).
All analyses were performed using SPSS, version 20
(SPSS, Chicago, IL, USA). A two-sided p value less than
0.05 was considered to be statistically significant.
Results
Patient characteristics
In this study, 275 patients with severe sepsis and septic
shock were enrolled. Thirty-five patients were excluded
because they had pre-existing chronic renal failure. Thus,
240 patients were eligible for further evaluation (Fig. 1).
Of these, 98 patients (40.8 %) had hyperchloremia within
the first 48 hours of resuscitation and 142 patients
(59.2 %) did not have hyperchloremia. Demographics,
baseline characteristics and clinical outcome of patients
with hyperchloremia and without hyperchloremia are
shown in Table 1. Patients with hyperchloremia had a
higher heart rate and APACHE II score, vasopressor and
ventilator requirement. Comorbidities, serum lactate and
fluid intake/output were not different between the two
groups. Baseline serum creatinine also was not signifi-
cantly different in both groups. Notably, there was no
difference in serum chloride before full resuscitation
between those patients who developed hyperchloremia
([Cl-]0 104.3 ± 7.7 mmol/L) and those who did not ([Cl
-]0
103.7 ± 4.6 mmol/L, p = 0.51).
Univariate analysis
Serum chloride and acute kidney injury
The initial serum chloride, [Cl-]0, before full resuscita-
tion was not associated with development of AKI [odds
ratio 1.01 (0.97–1.05); p = 0.51]. The incidence of AKI
was significantly higher in the hyperchloremia group (84
of 98 = 85.7 % versus 68 of 142 = 47.9 %; p < 0.001). The
maximum chloride concentration within the first
48 hours, [Cl-]max, was associated with AKI with an odds
ratio 1.14 per mmol [Cl-] (95 % CI 1.08–1.20, p < 0.001)
(Table 2). Non-significant trends for patients with hyper-
chloremia, compared to those without hyperchloremia,
included a need of RRT (7.1 % versus 3.5 %; p = 0.206)
and 28-day mortality (6.1 % versus 1.4 %; p = 0.066).
Increase in serum chloride and severity of AKI
The increase in serum chloride, Δ[Cl-] (= [Cl-]max - [Cl
-]0),
was strongly associated with AKI. The odds ratio for de-
velopment of AKI for Δ[Cl-] was 1.25 per mmol Δ[Cl-]
(95 % CI 1.16–1.36; p < 0.001), which was a stronger effect
than for [Cl-]max. Importantly, Δ[Cl
-] remained signifi-
cantly associated with development of AKI even in those
patients who were never hyperchloremic with an odds ra-
tio of 1.37 per mmol Δ[Cl-] (95 % CI 1.20–1.56). A dose-
response relationship of Δ[Cl-] and severity of AKI was
observed; the greater the Δ[Cl-], the more severe the AKI
stage. The mean Δ[Cl-] in patients without AKI was
2.06 mmol/L, for AKI stage 1 Δ[Cl-] was 5.14 mmol/L, for
AKI stage 2 Δ[Cl-] was 5.88 mmol/L, and for AKI stage 3
Δ[Cl-] was 6.70 mmol/L (Fig. 2).
Moderate increase in serum chloride and AKI
Since AKI stage 1, 2, and 3 were all associated with a
mean Δ[Cl-] ≥ 5 mmol/L we used this value as a threshold.
A moderate increase in serum chloride (Δ[Cl-] ≥ 5 mmol/
L) identified patients with an odds ratio of developing any
AKI of 5.70 (3.00–10.82); p < 0.001 and an odds ratio of
developing more severe AKI (AKI stage 2 and 3) of 3.40
(1.95–5.94); p < 0.001. Interestingly, in patients without
hyperchloremia, Δ[Cl-] ≥ 5 mmol/L was also associated
with AKI (OR = 8.25, 95 % CI 3.44–19.78; p < 0.001) and
Fig. 1 Flow chart of the patients with severe sepsis and septic shock
in the study. [Cl-]max maximal chloride concentration in the first
48 hours, AKI acute kidney injury, CRF chronic renal failure
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more severe AKI (AKI stage 2 and 3) (OR = 4.8, 95 % CI
2.1–10.7; p < 0.001) (Table 3).
Multivariate analysis
To adjust for baseline differences we incorporated age,
gender and all potentially confounding variables [with
p < 0.1 in univariate logistic regression analysis; hyper-
tension, congestive heart failure, chronic obstructive
pulmonary disease (COPD), APACHE II score, serum lac-
tate, vasopressor and ventilator requirement] into the
multivariate model. [Cl-]max remained significantly associ-
ated with AKI (OR = 1.35, 95 % CI 1.09–1.66, p = 0.006).
Norepinephrine dosage was included quantitatively in
the multivariable model and, while associated with
AKI in the univariate analysis, it sufficiently covaried
with other factors in the multivariate model (e.g.,
mean arterial pressure, APACHE II score) so that this
association was not significant in the multivariate
model. In contrast serum chloride remained an inde-
pendent predictor of AKI (Table 4).







Age, yr, mean ± SD 57.5 ± 15.1 52.9 ± 18.4 0.05
Male, % 46.9 55.6 0.38
Underlying diseases
Hypertension, % 36.7 28.2 0.074
Ischemic heart disease, % 6.1 5.6 0.65
CHF, % 4.1 8.5 0.10
DM, % 21.4 21.1 0.71
COPD, % 21.4 18.3 0.086
Cirrhosis, % 7.1 4.9 0.082
Malignancy, % 4.1 5.6 0.20
HIV, % 11.2 9.2 0.56
Chronic steroid treatment, % 5.1 6.3 0.91
Clinical parameters at presentation
MAP, mean ± SD 85 ± 21 89 ± 17 0.12
HR, mean ± SD 104 ± 22 96 ± 21 0.003a
Lactate, mean ± SD 2.9 ± 2.8 2.5 ± 2.4 0.29
Creatinine(mg/dL), median (IQR) 1.0 (0.7-1.4) 0.9 (0.4-1.4) 0.49
APACHE II score, mean ± SD 11.3 ± 5.0 7.8 ± 5.4 <0.001a
Clinical parameters at 24 hr
Vasopressor, % 31 11 <0.001a
Mechanical ventilator, % 64 32 <0.001a
Fluid intake, mean ± SD 4959 ± 3,417 4691 ± 2,341 0.71
Urine output, mean ± SD 2416 ± 1,146 2554 ± 1,463 0.644
Chloride parameters
Initial chloride ([Cl-]0), mean ± SD 104.3 ± 7.7 103.7 ± 4.6 0.51
Maximal Cl in 48 hours ([Cl-]max) 104.4 ± 3.7 114.4 ± 3.6 <0.001
a
Increase in serum Cl (Δ[Cl-]) 3.2 ± 4.2 6.1 ± 5.0 <0.001a
Clinical outcome
AKI, % 85.7 47.9 <0.001a
RRT, % 7.1 3.5 0.206
28-day mortality, % 6.1 1.4 0.066
SD standard deviation, CHF congestive heart failure, DM diabetes mellitus, COPD chronic obstructive pulmonary disease, HIV human immunodeficiency virus, MAP
mean arterial pressure, HR heart rate, IQR interquartile rate, APACHE Acute Physiology and Chronic Health Evaluation, [Cl-]0 initial chloride concentration, [Cl
-]max
maximal chloride concentration in the first 48 hours, Δ[Cl-] increase in serum chloride; AKI acute kidney injury, RRT renal replacement therapy
aIndicates statistical significance, p < 0.05
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Serum sodium and bicarbonate and AKI
To test an alternative explanation that serum chloride was
simply a marker of the degree of volume resuscitation, we
repeated the multivariate analysis using alternative elec-
trolytes that would similarly covary with Saline volume re-
suscitation. The multivariable analysis was repeated using
initial and maximal serum sodium and initial and maximal
serum bicarbonate. None of these variables were signifi-
cant independent predictors of AKI (Table 4).
Discussion
The main result of this study is hyperchloremia is com-
mon and significantly associated with AKI in severe sep-
sis and septic shock patients. Although initial serum
chloride concentration before volume resuscitation did
not correlate with development of AKI, maximal serum
chloride concentration in the first 48 hours ([Cl-]max)
and the increase in serum chloride (Δ[Cl-]) were signifi-
cantly associated with AKI. Because the patients in the
hyperchloremia group had higher APACHE II score,
vasopressor and ventilator requirement that might result
in higher AKI than the patients in the normochloremia
group rather than by hyperchloremia, we use a multivari-
ate logistic regression model to minimize the effect of
these confounders. After several potential confounders
such as age, gender, hypertension, congestive heart failure,
COPD, APACHE II score, serum lactate, vasopressor and
ventilator requirement were adjusted for in the multivari-
ate logistic regression model, [Cl-]max remained independ-
ently associated with AKI. Moreover, an increase in serum
chloride was associated with AKI and more severe AKI
(AKI stage 2 and 3). Importantly, Δ[Cl-] ≥ 5 mmol/L was
associated with the development of AKI even in the pa-
tients who never developed hyperchloremia. Thus, these
data suggest that a rapid change in serum chloride con-
centration may be more important than the absolute value
of serum chloride in causing AKI.
To our knowledge this is the first report of the associ-
ation of a moderate increase in serum chloride (Δ[Cl-] ≥
5 mmol/L) and development of AKI in severe sepsis and
septic shock, even in patients without hyperchloremia.
Our results are consistent with a retrospective study of
unselected critically ill patients in which there was an as-
sociation of maximal chloride concentration and the de-
velopment of AKI [18]. Our study used serum chloride
concentration in the first 48 hours to define hyperchlor-
emia and found the association of [Cl-]max with the de-
velopment of AKI in severe sepsis and septic shock. We
obtained chloride measurements prior to significant vol-
ume resuscitation and found that this initial serum
chloride concentration ([Cl-]0) was not associated with
development of AKI. Previous studies found a relation-
ship between initial chloride concentration and develop-
ment of AKI, although these initial measurements may
have followed a substantial saline resuscitation [19, 20].
More recently, a double-blind randomized trial evaluat-
ing the effect of Saline versus Plasma-Lyte in the inten-
sive care unit (the SPLIT trial) demonstrated no
difference of AKI incidence and severity between the
two groups [23]. However, most patients were postoper-
ative (71 %) and only 4 % of patients were diagnosed as
sepsis. Overall incidence of AKI by KDIGO criteria was
lower (27 %) compared to what we observed (63 %) in
our sepsis/septic shock population. The volume of crys-
talloid solution used in that trial (2000 mL) was much
less than the average volume that was infused in our pa-
tients (4825 mL). This study did not report serum chlor-
ide concentrations so it is unknown whether this small
volume of Saline resuscitation over an extended period
of time was sufficient to cause either hyperchloremia or
Δ[Cl-] ≥ 5 mmol/L.
We did not find a statistically significant association
between hyperchloremia and need for RRT although we
observed a trend in this direction. A previous study
found a similar statistically significant trend in the asso-
ciation of chloride restrictive strategy and reduction of
RRT requirement [17]. However, we excluded the pa-
tients with pre-existing chronic renal failure and need of
RRT in our study was lower (5 % vs 10 %). Second, a
Table 2 Univariate logistic regression model to test association
of AKI and initial serum chloride ([CL-]0), maximal serum chloride
in first 48 hours ([Cl–]max), and increase in serum chloride
(Δ[Cl-] = [Cl-]max–[CL
-]0)
Variable AKI stage 1 to 3 p AKI stage 2 and 3 p
Odds ratio (95 % CI) Odds ratio (95 % CI)
[CL-]0 1.01 (0.97–1.05) 0.478 0.99 (0.95–1.03) 0.562
[Cl-]max 1.14 (1.08–1.20) <0.001
a 1.07 (1.02–1.12) 0.006a
Δ[CL-] 1.25 (1.16–1.36) <0.001a 1.14 (1.07–1.21) <0.001a
AKI acute kidney injury, [Cl-]0 initial chloride concentration, [Cl
-]max maximal
chloride concentration in the first 48 hours, Δ[Cl-] increase in serum chloride,
CI confidence interval
aIndicates statistical significance, p <0.05
Fig. 2 Increase in serum chloride and AKI severity. The mean increase
in serum chloride (Δ[Cl-]) in AKI stage 1, 2 and 3 is significantly higher
than in patients without AKI (p < 0.05) and these data suggest a dose-
response relationship between Δ[Cl-] and AKI stage. Δ[Cl-] increase in
serum chloride, AKI acute kidney injury,
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smaller sample size in our study limited the statistical
power of detection. Moreover, our populations were
exclusively severe sepsis or septic shock while in the pre-
vious study only 7 % were severe sepsis or septic shock.
Normal saline solution was originally called “indiffer-
ent” saline because it was recognized that human eryth-
rocytes did not lyse in the 0.9 % NaCl solution [24].
Despite being called “normal saline” solution, it has a near
physiological concentration of sodium (154 mmol/L) but
supraphysiologic concentration of chloride (154 mmol/L
or 1.5 times of normal serum chloride concentration) [25].
Infusion of 0.9 % NaCl is significantly associated with
hyperchloremic metabolic acidosis in both healthy volun-
teers and various types of patient [26–35]. The clinical
significance of iatrogenic hyperchloremic metabolic acid-
osis remains uncertain. The hospital mortality is much
higher in lactic acidosis than in hyperchloremic acidosis
(56 % vs 29 %) compared with the hospital mortality of pa-
tients without acidosis (26 %) [36].
Supraphysiologic serum chloride concentration has
detrimental effects on renal function. In animal models,
infusion of 0.9 % NaCl resulted in renal vasoconstriction
and decreased renal blood flow and glomerular filtration
rate [13, 37–39] possibly due to chloride-induced
thromboxane release [38] and augmented response to
renal vasoconstrictors such as angiotensin II [40]. Fur-
thermore, the tubuloglomerular feedback mechanism
initiated by detection of chloride at the macula densa re-
sults in afferent arteriolar vasoconstriction, mesangial
contraction and decreased glomerular filtration rate [41].
In healthy human volunteers, infusion of normal saline
caused reductions in renal artery blood flow, renal cor-
tical perfusion [14] and delayed first micturition [15, 27].
Saline infusion resulted in a higher incidence of AKI
when compared with balanced crystalloids [17, 42, 43].
In an animal model of sepsis, resuscitation of septic ani-
mals with Saline resulted in not only higher incidence of
AKI and greater severity of AKI but also higher inflam-
matory mediator concentrations (IL-6) when compared
to Plasma-Lyte [16]. Interestingly, the study of effect of
an acute Saline infusion on fluid and electrolyte metab-
olism revealed that the human body required 2 days to
restore electrolyte and fluid balance to equilibrium [44].
There are several limitations to this study. First, it was
a retrospective cohort study so the association of hyper-
chloremia with AKI does not necessarily imply causality.
Second, we were not able to determine the amount of
chloride administered from the medical records so the
analysis is based on the consequence – the change in
serum chloride concentration. Hyperchloremia may have
negative effects on renal function and cause AKI. Alter-
natively, increased severity of shock would lead to AKI
and increased administration of Saline without a causal
Table 3 Univariate logistic regression model to test association of AKI and increase in serum chloride (ΔCL = [Cl-]max - CL0) in all
patients and patients without hyperchloremia
Variable AKI stage 1 to 3 p AKI stage 2 and 3 p
Odds ratio (95 % CI) Odds ratio (95 % CI)
All patients
Δ[Cl-] 1.25 (1.16–1.36) <0.001a 1.14 (1.07–1.20) <0.001a
Δ[Cl-]≥ 5 mmol/l 5.70 (3.00–10.82) <0.001a 3.40 (1.95–5.94) <0.001a
Patients without hyperchloremia
Δ[Cl-] 1.37 (1.20–1.56) <0.001a 1.25 (1.13–1.38) <0.001a
Δ[Cl-]≥ 5 mmol/l 8.25 (3.44–19.78) <0.001a 4.77 (2.13–10.70) <0.001a
AKI acute kidney injury, Δ[Cl-] increase in serum chloride, [Cl-]max maximal chloride concentration in the first 48 hours, [Cl
-]0 initial chloride concentration, CI
confidence interval
aIndicates statistical significance, p < 0.05
Table 4 Multivariate logistic regression of association of AKI
with initial serum chloride ([Cl-]0), maximal serum chloride
([Cl-]max), initial serum sodium (Na0) and maximal serum
sodium(Namax)
OR 95 % confidence interval p
Age 0.99 0.95 1.04 0.776
Sex (male) 0.40 0.09 1.77 0.228
Hypertension 0.68 0.13 3.70 0.656
APACHE II 1.55 1.19 2.03 0.001a
Serum lactate 1.60 0.84 3.04 0.155
Norepinephrine dosage 1.06 0.82 1.36 0.680
Ventilator requirement 3.95 0.57 27.44 0.165
[Cl-]0 0.87 0.70 1.10 0.240
[Cl-]max 1.28 1.02 1.62 0.037
a
Δ[Cl-] 1.32 1.07 1.61 0.008a
Na0 1.01 0.76 1.35 0.825
Namax 1.03 0.81 1.31 0.825
Multivariate logistic regression model was adjusted by incorporating all
potentially confounding factors including age, gender, underlying diseases,
initial serum lactate, APACHE II score and requirement of vasopressor
and ventilator
AKI acute kidney injury, OR odds ratio, APACHE Acute Physiology and Chronic
Health Evaluation
aIndicates statistical significance, p < 0.05
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relationship between the two. Second, these results do not
address the mechanism or pathophysiology of hyperchlor-
emia and AKI. Finally, the small sample size significantly
limits power to detect an association of hyperchloremia or
Δ[Cl-] with RRT and 28-day mortality.
Conclusions
Hyperchloremia is common in severe sepsis and septic
shock patients and is independently associated with AKI.
Initial serum chloride concentration is not associated with
the development of AKI while hyperchloremia, defined as
the maximum serum chloride concentrations measure-
ment in the first 48 hours, is associated with development
of AKI. Our most striking finding is the association of
moderate increase in serum chloride (Δ[Cl-] ≥ 5 mmol/L)
and AKI even in patients who had serum chloride within
the normal range. Finally, there is a continuing need for
RCTs of intravenous fluid in sepsis and septic shock that
address the risks of saline vs. balanced solutions for devel-
opment of AKI. Perhaps serum chloride could be a bio-
marker for response to various intravenous fluids.
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